NCT01215513 - Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Prostate Cancer

Interventions

DRUG

Degarelix

Trial Locations (11)

Korea University Hospital, Seoul

Seoul St. Mary's Hospital, Seoul

Kyoungbuk National University Hospital, Daegu

Yonsei University Health System Gangnam Sevrance, Seoul

Seoul National University Bundang Hospital, Seongnam-si

Hallym University Sacred Heart Hospital, Pyungchon

Pusan National University Yangsan Hospital, Mulgeum-eup

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

Yonsei University Health System (Sevrance Hospital), Seoul

Seoul National University Hospital, Seoul